Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information

Mar 29, 2011, 17:59 ET from Commonwealth Biotechnologies Inc.

$codeDebug.log("output array of get country targets countryT

NEW HAVEN, Conn., March 29, 2011 /PRNewswire/ -- USChina Channel LLC announced today:

On March 11, 2011, Bill Guo, Chairman of Commonwealth Biotechnologies Inc. ("CBI") filed Form 8-k of SEC, to announce the detail of 2011 Annual Shareholder Vote & Meeting. The vote process is going very well.

We already have shareholders representing over 3 million shares of common stock made the vote. Followings are the interim vote results for the four proposals:

PROPOSAL 001 ELECTION OF DIRECTOR: BILL GUO


FOR

AGAINST

ABSTAIN

BROKER NONE-VOTES

BENEFICIAL

366,658

21,848

0


REGISTERED

2,615,693

0

0


TOTAL SHARE VOTED

2,982,351

21,848

0


% OF VOTED

99.27%

0.72%

0.00%


% OF OUTSTANDING

24.66%

0.18%

0.00%





PROPOSAL 002 REVISE OF ARTICLE OF CBI & ACCEPT MIN. 1 MEMBER OF DIRECTORS OF BOARD


FOR

AGAINST

ABSTAIN

BROKER NONE-VOTES

BENEFICIAL

365,658

22,848

0


REGISTERED

2,615,693

0

0


TOTAL SHARE VOTED

2,981,351

22,848

0


% OF VOTED

99.23%

0.76%

0.00%


% OF OUTSTANDING

24.65%

0.18%

0.00%





PROPOSAL 003 REVISE OF BYLAWS OF CBI & ACCEPT MIN. 1 MEMBER OF DIRECTORS OF BOARD


FOR

AGAINST

ABSTAIN

BROKER NONE-VOTES

BENEFICIAL

365,658

22,848

0


REGISTERED

2,615,693

0

0


TOTAL SHARE VOTED

2,981,351

22,848

0


% OF VOTED

99.23%

0.76%

0.00%


% OF OUTSTANDING

24.65%

0.18%

0.00%





PROPOSAL 004 SALARY & COMPES. OF NEW DIRECTOR WILL BE $1 PER YEAR


FOR

AGAINST

ABSTAIN

BROKER NONE-VOTES

BENEFICIAL

388,206

300

0


REGISTERED

2,615,693

0

0


TOTAL SHARE VOTED

3,003,899

300

0


% OF VOTED

99.99%

0.00%

0.00%


% OF OUTSTANDING

24.83%

0.00%

0.00%





There are 99.99% of the voted shares approved the proposal that the salary and compensation of new director(s) would be $1 per year. To cut the overhead expenses sharply became the whelming demands of the voted shareholders.

These shareholders, who haven't voted, could go to www.proxyvote.com making a vote now. Whether you agree or disagree, your voice is important for CBI which is in a critical status for fighting surviving.

We welcome all shareholders to attend the CBI 2011 Annual Shareholders Meeting, which will be held at 10:00 a.m. EDT, on April 4, 2011. The meeting will be held electronically via telecom.  Here is the url address that has been assigned for your virtual annual meeting: 

http://www.virtualshareholdermeeting.com/CBTE

Shareholders will be able to log onto the above site approximately 15 minutes prior to the meeting to listen to the proceedings, view the annual meeting materials, vote their shares and ask a question if they choose to do so. 

Since we suspended SEC reporting status, shareholders could go to the url address www.otcmarkets.com from CBI trading symbol or name to find the limited communication between company and public.

If you have any question, please contact:

Bill Guo  


Address: Venturepharm Towers

USA: C/o Agent: Andrew Chien

No. 3 Jinzhuang, Sijiqing, Haidian District

665 Ellsworth Avenue

Beijing, China PC 100089

 New Haven, CT 06511

Tel: 86-10-88500088

Tel: 203-8440809

Fax: 86-10-88500080

Fax: 8665716313

E-mail: la@venturepharm.com

E-mail: uschien@uschinachannel.net




We hired InvestorCom, Inc to do proxy solicitation, and any one could contact them by:

John Glenn Grau, President.  InvestorCom, Inc., www.investor-com.com

65 Locust Avenue, Third Floor,  New Canaan, CT   06840

P (203) 972-9300 ext. 11   F (203) 966-6478    M (646) 242-0410

45 Park Avenue, Suite 3900, New York, NY   10167

P (212) 668-0800



SOURCE Commonwealth Biotechnologies Inc.